News Quantified

SCPH – scpharmaceuticals inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.

scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

-2.6%

BEAT

-8.7%

MISS

1.3%

BEAT

-1.4%

BEAT

Form DEFA14A scPharmaceuticals Inc.

Form DEF 14A scPharmaceuticals Inc. For: Jun 11

Form PRE 14A scPharmaceuticals Inc. For: Jun 11

Form SC 13G/A scPharmaceuticals Inc. Filed by: BlackRock Inc.

Form 4 scPharmaceuticals Inc. For: Mar 29 Filed by: Tucker John H

Top News Gainers

3/24 Q4/2019 12/31/2019 EPS -0.270 ZacksConsensus -0.540 ActVsEst 0.270 - Beat 40.7%

8/7 Q2/2019 6/30/2019 EPS -0.390 ZacksConsensus N/A ActVsEst N/A - N/A 16.9%

2/19 Form 4 scPharmaceuticals Inc. For: Feb 14 Filed by: Kolchinsky Peter 14.0%

3/24 Form S-8 scPharmaceuticals Inc. 11.0%

10/31 Scpharmaceuticals Inc (NASDAQ: SCPH) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 8.0%

12/12 scPharmaceuticals Inc. Announces Recent Progress on FUROSCIX® and Highlights Corporate Objectives 6.8%

8/15 scPharmaceuticals (SCPH) Presents At Wedbush PacGrow Healthcare Conference - Slideshow [Seeking Alpha] 5.8%

12/21 Scpharmaceuticals Inc (NASDAQ: SCPH) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.8%

5/8 Q1/2019 3/31/2019 EPS -0.470 ZacksConsensus -0.590 ActVsEst 0.120 - Beat 4.8%

8/10 Scpharmaceuticals Inc (NASDAQ: SCPH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.25 price target on the stock. 4.4%

Top News Decliners

11/14 scPharmaceuticals Inc. to Present at the Jefferies 2019 London Healthcare Conference -11.5%

6/20 Form 4 scPharmaceuticals Inc. For: Jun 18 Filed by: VEITINGER KLAUS R DR -10.1%

12/14 Scpharmaceuticals Inc (NASDAQ: SCPH) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -7.6%

11/14 Scpharmaceuticals Inc (NASDAQ: SCPH) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -7.5%

11/12 Q3/2019 9/30/2019 EPS -0.330 ZacksConsensus -0.430 ActVsEst 0.100 - Beat -6.9%

8/7 Form 10-Q scPharmaceuticals Inc. For: Jun 30 -5.8%

8/23 Form 424B5 scPharmaceuticals Inc. -5.7%

1/11 Scpharmaceuticals Inc (NASDAQ: SCPH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.50 price target on the stock. -5.3%

5/30 scPharmaceuticals Inc. to Present at Upcoming Investor Conferences -5.2%

11/26 scPharmaceuticals Inc. to Present at the Piper Jaffray 31st Annual Healthcare Conference -5.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day